Merit Medical Systems, Inc. (MMSI)

NASDAQ: MMSI · Real-Time Price · USD

Compare

82.50

+2.87 (3.60%)

At close: Feb 6, 2026, 4:00 PM EST

82.50

0.00 (0.00%)

After-hours: Feb 6, 2026, 4:20 PM EST

Merit Medical Systems Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Revenue	1,477	1,357	1,257	1,151	1,075	963.88
Revenue Growth (YoY)	11.41%	7.89%	9.24%	7.09%	11.50%	-3.11%
Cost of Revenue	761.23	713.18	673.49	631.88	589.42	562.7
Gross Profit	715.9	643.33	583.87	519.1	485.33	401.18
Selling, General & Admin	448.36	396.63	370.98	335.33	329.69	297.72
Research & Development	96.01	87.47	82.73	75.51	71.25	57.54
Operating Expenses	544.36	484.1	453.7	410.84	400.94	355.26
Operating Income	171.54	159.24	130.17	108.26	84.4	45.92
Interest Expense	-28.09	-31.22	-15.51	-6.34	-5.26	-9.99
Interest & Investment Income	15.91	26.23	2.46	0.44	0.77	0.6
Currency Exchange Gain (Loss)	3.01	1.96	2	1.42	-1.6	-2.19
Other Non Operating Income (Expenses)	-4.89	-2.67	-0.8	-0.45	-0.91	-0.61
EBT Excluding Unusual Items	157.47	153.54	118.31	103.33	77.4	33.73
Merger & Restructuring Charges	-3.1	-3.1	-2.7	-7.2	-2.7	-
Gain (Loss) on Sale of Investments	-	-	-0.27	-0.5	-	-6
Gain (Loss) on Sale of Assets	-	-	-	-	-	0.52
Asset Writedown	-	-	-	-1.72	-1.58	-30.5
Legal Settlements	-	-	-	-	-10.04	-18.68
Other Unusual Items	-1.35	-0.44	-1.7	-4.61	-9.16	7.96
Pretax Income	153.02	149.99	112.09	82.63	53.92	-13.23
Income Tax Expense	34.59	29.64	17.68	8.11	5.46	-3.39
Net Income	118.43	120.36	94.41	74.52	48.45	-9.84
Net Income to Common	118.43	120.36	94.41	74.52	48.45	-9.84
Net Income Growth	-1.34%	27.48%	26.70%	53.79%	-	-
Shares Outstanding (Basic)	59	58	58	57	56	55
Shares Outstanding (Diluted)	61	59	58	58	57	55
Shares Change (YoY)	3.06%	1.73%	1.19%	0.54%	3.47%	-1.42%
EPS (Basic)	2.01	2.07	1.64	1.31	0.86	-0.18
EPS (Diluted)	1.95	2.03	1.62	1.29	0.84	-0.18
EPS Growth	-4.83%	25.31%	25.58%	53.57%	-	-
Free Cash Flow	206.88	185.66	110.86	69.26	119.29	119.28
Free Cash Flow Per Share	3.41	3.13	1.90	1.20	2.08	2.15
Gross Margin	48.47%	47.42%	46.44%	45.10%	45.16%	41.62%
Operating Margin	11.61%	11.74%	10.35%	9.41%	7.85%	4.76%
Profit Margin	8.02%	8.87%	7.51%	6.47%	4.51%	-1.02%
Free Cash Flow Margin	14.01%	13.69%	8.82%	6.02%	11.10%	12.38%
EBITDA	291.78	261.95	220.15	190.07	168.46	139.99
EBITDA Margin	19.75%	19.31%	17.51%	16.51%	15.68%	14.52%
D&A For EBITDA	120.25	102.71	89.99	81.8	84.07	94.07
EBIT	171.54	159.24	130.17	108.26	84.4	45.92
EBIT Margin	11.61%	11.74%	10.35%	9.41%	7.85%	4.76%
Effective Tax Rate	22.61%	19.76%	15.77%	9.82%	10.13%	-

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q